KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Change in Inventory: 2010-2025

Historic Change in Inventory for Opko Health (OPK) over the last 15 years, with Sep 2025 value amounting to -$624,000.

  • Opko Health's Change in Inventory rose 86.78% to -$624,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $7.5 million, marking a year-over-year increase of 142.84%. This contributed to the annual value of -$4.2 million for FY2024, which is 72.25% up from last year.
  • As of Q3 2025, Opko Health's Change in Inventory stood at -$624,000, which was down 230.54% from $478,000 recorded in Q2 2025.
  • In the past 5 years, Opko Health's Change in Inventory registered a high of $27.9 million during Q1 2021, and its lowest value of -$24.1 million during Q2 2021.
  • Its 3-year average for Change in Inventory is -$1.3 million, with a median of -$1.3 million in 2023.
  • Its Change in Inventory has fluctuated over the past 5 years, first plummeted by 373.38% in 2023, then surged by 339.09% in 2025.
  • Quarterly analysis of 5 years shows Opko Health's Change in Inventory stood at -$16.4 million in 2021, then spiked by 85.71% to -$2.3 million in 2022, then crashed by 373.38% to -$11.1 million in 2023, then skyrocketed by 120.11% to $2.2 million in 2024, then surged by 86.78% to -$624,000 in 2025.
  • Its Change in Inventory stands at -$624,000 for Q3 2025, versus $478,000 for Q2 2025 and $5.4 million for Q1 2025.